All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Source-checked decision dossier

Cheapest Tirzepatide Without Insurance: Compare the Complete Cost

Compare Zepbound and compounded tirzepatide price structures using current provider and manufacturer sources.

Verified 2026-08-253 claim-level citationsMethodology

Bottom line

What is the lowest verifiable tirzepatide price without insurance after required fees?

Mochi currently publishes the lowest entry price in this sourced set for compounded tirzepatide, but its medication price is dose-based and membership is separate. LillyDirect publishes brand Zepbound from $299 to $449. FormBlends publishes compounded tirzepatide at $349. Medication status and full program cost matter more than the headline number.

Primary-source comparison

Every row links to the provider or regulator used. “Verify” means the public source did not establish that field clearly enough to score it.

OptionAdvertised floorProduct statusFull published rangeSeparate feeConditions
Mochi$90Compounded; not FDA-approved$90–$199Membership separateDose, state, pharmacy
LillyDirect$299FDA-approved Zepbound$299–$449No telehealth fee shownDose and refill timing
FormBlends$349Compounded; not FDA-approvedNot publishedNo separate fee shownProvider review

Claims and evidence

Each claim carries its own scope, verification date, and source—not a generic bibliography at the bottom of the page.

Mochi publishes compounded tirzepatide from $90 to $199 per month depending on dose, state, and pharmacy.
Scope: Medication price only; membership and qualification remain separate.
Source verifiedVerified 2026-08-252 sources
  1. Mochi Health: New Per-Dose Pricing: What Changed Accessed 2026-08-25.
  2. Mochi Health: Online Medical Weight Loss Program Accessed 2026-08-25.
LillyDirect publishes FDA-approved Zepbound from $299 to $449 per month by dose under its self-pay program.
Scope: Higher-dose $449 pricing requires published refill conditions.
Source verifiedVerified 2026-08-251 source
  1. Eli Lilly: Authentic Zepbound shipped to you Accessed 2026-08-25.
A compounded tirzepatide prescription and FDA-approved Zepbound should not be described as the same finished drug product.
Scope: They may reference the same active ingredient, but compounded products are not FDA-approved and do not undergo the same premarket review.
Source verifiedVerified 2026-08-251 source
  1. U.S. Food and Drug Administration: Questions and Answers: Outsourcing Facility Registration Accessed 2026-08-25.

Reproducible methodology

How this page was built

  1. 1.Use provider, manufacturer, and regulator pages as primary sources; do not score claims copied from review sites.
  2. 2.Record the exact access date and distinguish starting prices, ongoing prices, membership fees, medication fees, and dose-dependent pricing.
  3. 3.Treat any field that cannot be reproduced from a primary source as not verified instead of estimating it.
  4. 4.Recheck volatile price and availability claims at least monthly and retain a public change log.

Verification

Last checked 2026-08-25. This page uses 4 disclosed sources and preserves unresolved fields as “not verified.”

Commercial disclosure

FormBlends sells telehealth programs and may benefit when a reader chooses FormBlends. Competitors are evaluated from their own published materials. Payment or affiliate relationships do not affect inclusion or source status.

Next decision

Use the evidence, then choose your path.

Check FormBlends tirzepatide details